Sickle cell anemia (SCA) causes dysfunction of multiple organs, with pulmonary involvement as a major cause of mortality. Recently, there has been growing interest in the nitrogen single-breath ...washout (N2SBW) test, which is able to detect ventilation heterogeneity and small airway disease when the results of other pulmonary function tests (PFTs) are still normal. Thus, the objectives of the present study were to assess the heterogeneity in the ventilation distribution in adults with SCA and to determine the association between the ventilation distribution and the clinical, cardiovascular, and radiological findings. This cross-sectional study included 38 adults with SCA who underwent PFTs, echocardiography, computed tomography (CT), and 6-min walk test. To evaluate the ventilation heterogeneity, the patients were categorized according to the phase III slope of the N2SBW (SIIIN2). Compared with adults with lower SIIIN2 values, adults with higher SIIIN2 values showed lower hemoglobin levels (P=0.048), a history of acute chest syndrome (P=0.001), an elevated tricuspid regurgitation velocity (P=0.039), predominance of a reticular pattern in the CT (P=0.002), a shorter 6-min walking distance (6MWD) (P=0.002), and lower peripheral oxygen saturation (SpO2) after exercise (P=0.03). SIIIN2 values correlated significantly with hemoglobin (rs=-0.344; P=0.034), forced vital capacity (rs=-0.671; P<0.0001), diffusing capacity for carbon monoxide (rs=-0.376; P=0.019), 6MWD (rs=-0.554; P=0.0003), and SpO2 after exercise (P=0.040). Heterogeneity in the ventilation distribution is one of the most common pulmonary dysfunctions in adults with SCA. Moreover, relationships exist between ventilation heterogeneity, worsening of pulmonary structural damage, and reduced tolerance for exercise.
Abstract
Motivation
Visualization of multiple genomic data generally requires the use of public or commercially hosted browsers. Flexible visualization of chromatin interaction data as genomic ...features and network components offer informative insights to gene expression. An open source application for visualizing HiC and chromatin conformation-based data as 2D-arcs accompanied by interactive network analyses is valuable.
Results
DNA Rchitect is a new tool created to visualize HiC and chromatin conformation-based contacts at high (Kb) and low (Mb) genomic resolutions. The user can upload their pre-filtered HiC experiment in bedpe format to the DNA Rchitect web app that we have hosted or to a version they themselves have deployed. Using DNA Rchitect, the uploaded data allows the user to visualize different interactions of their sample, perform simple network analyses, while also offering visualization of other genomic data types. The user can then download their results for additional network functionality offered in network based programs such as Cytoscape.
Availability and implementation
DNA Rchitect is freely available both as a web application written primarily in R available at http://shiny.immgen.org/DNARchitect/ and as an open source released under an MIT license at: https://github.com/alosdiallo/DNA_Rchitect.
Introduction:
The purpose of this study was to compare the effects of benazepril and losartan on endothelial function and vascular stiffness, in patients with diabetes mellitus and hypertension.
...Materials and methods:
We included hypertensive diabetic patients with an office systolic blood pressure (BP) ⩾ 130 mmHg and/or diastolic BP ⩾ 80 mmHg. Patients were rolled over to amlodipine for 6 weeks, then we performed C-reactive protein assays, BP measurement and vascular tests; next, patients were randomized to benazepril or losartan. The tests were repeated after 12 weeks.
Results:
We randomized 14 patients to benazepril and 16 to losartan. There were no differences in systolic (139 versus 134 mmHg, p = 0.618) and diastolic (82 versus 80 mmHg, p = 0.950) BP at the end of the study. C-reactive protein values were lower in the benazepril group (0.38 versus 0.42 mg/dl, p = 0.020). There was a slightly higher flow-mediated vasodilation (FMD) response in the benazepril group (45% increase, p = 0.057) than in the losartan group (19% increase, p = 0.132). Both central systolic BP (129 versus 123 mmHg, p = 0.934) and carotid-femoral pulse wave velocity (cfPWV) (8.5 versus 8.5 m/s, p = 0.280) were the same between groups.
Conclusions:
Hypertensive diabetic patients using benazepril had a greater reduction in C-reactive protein, and a slight improvement in FMD, than those taking losartan.
Apolipoprotein D Rassart, Eric; Bedirian, Arda; Do Carmo, Sonia ...
Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular Enzymology,
10/2000, Letnik:
1482, Številka:
1
Book Review, Journal Article
Recenzirano
Apolipoprotein D (apoD) is a 29-kDa glycoprotein that is primarily associated with high density lipoproteins in human plasma. It is an atypical apolipoprotein and, based on its primary structure, ...apoD is predicted to be a member of the lipocalin family. Lipocalins adopt a β-barrel tertiary structure and transport small hydrophobic ligands. Although apoD can bind cholesterol, progesterone, pregnenolone, bilirubin and arachidonic acid, it is unclear if any, or all of these, represent its physiological ligands. The apoD gene is expressed in many tissues, with high levels of expression in spleen, testes and brain. ApoD is present at high concentrations in the cyst fluid of women with gross cystic disease of the breast, a condition associated with increased risk of breast cancer. It also accumulates at sites of regenerating peripheral nerves and in the cerebrospinal fluid of patients with neurodegenerative conditions, such as Alzheimer’s disease. ApoD may, therefore, participate in maintenance and repair within the central and peripheral nervous systems. While its role in metabolism has yet to be defined, apoD is likely to be a multi-ligand, multi-functional transporter. It could transport a ligand from one cell to another within an organ, scavenge a ligand within an organ for transport to the blood or could transport a ligand from the circulation to specific cells within a tissue.
OBJETIVO: Avaliar a função autonômica na cardiomiopatia hipertrófica (CMH) através da variabilidade da freqüência cardíaca (VFC) e correlacioná-la com dados ecocardiográficos. MÉTODOS: Foram ...estudados 2 grupos pareados por sexo, idade e freqüência cardíaca: A) 10 pacientes com CMH septal (70% não obstrutiva); B) 10 voluntários saudáveis. A VFC foi analisada durante quatro estágios sucessivos: repouso, respiração controlada, teste de inclinação e respiração controlada associada ao teste de inclinação. Compararam-se as médias das variáveis entre os grupos, intragrupos durante os estágios, e no grupo A, correlacionando com as medidas ecocardiográficas (septo interventricular e diâmetro atrial esquerdo). RESULTADOS: Não observamos diferença na VFC entre os grupos nos 3 primeiros estágios. No 4º estágio, constatamos que medidas de atividade vagal apresentaram valores maiores no grupo A logaritmo da raiz média quadrática das diferenças entre intervalos RR (LogRMSSD) - 1,35±0,14 vs 1,17±0,16; p=0,019; logaritmo do componente alta freqüência (LogAF)-4,89±0,22 vs 4,62±0,26; p=0,032. Durante os estágios, também verificamos que medidas vagais proporção de pares de intervalos RR consecutivos cuja diferença > 50ms (pNN50) e LogAF apresentaram menor redução durante o 3º estágio no grupo A, e o LogAF, um aumento no último estágio (p=0,027), indicando marcante atividade parassimpática neste grupo. A análise da VFC do grupo A não revelou diferença entre pacientes com maior hipertrofia ou diâmetro atrial. CONCLUSÃO: 1) ocorreu predomínio parassimpático durante estimulação autonômica nos pacientes com CMH; 2) não encontramos correlação entre VFC e as medidas ecocardiográficas analisadas.OBJECTIVE: Assess the autonomic function in hypertrophic cardiomyopathy (HCM) through heart rate variability (HRV) and to correlate it to echocardiographic data. METHODS: Two groups were studied, and compared for gender, age and HR:A) Ten (10) patients reporting septal HCM (70% non-obstructive); B) ten (10) healthy volunteers. HRV was analyzed along four successive stages: at rest, under controlled breathing, while bending, and controlled breathing associated to bending. Variables means were compared between groups and intra-groups in the different stages; in Group A, variables means were correlated to echocardiographic measurements (interventricular septum and left atrial diameter). RESULTS: No HRV difference was reported among groups in the first 3 stages. In the fourth stage vagal activity was shown to be higher in Group A quadratic mean log between RR intervals (RMSSD) - 1.35±0.14 vs 1.17±0.16; p=0.019; high frequency component logarithm (LogHF)- 4.89±0.22 vs 4.62±0.26; p=0.032. Along the stages, vagal measurements rate of pairs of consecutive RR intervals whose difference is > 50ms (pNN50) and LogHF also showed lower reduction in the third stage in Group A, while LogHF showed some increase in last stage (p=0.027), thus indicating marked parasympathetic activity in that group. Group A HRV analysis showed no difference among patients reporting larger hypertrophy or atrial diameter. CONCLUSION: 1) parasympathetic prevalence was shown during autonomic stimulation in HCM patients; 2) no correlation was found between HRV and echocardiographic measurements under analysis.
OBJETIVO: Avaliar a função autonômica na cardiomiopatia hipertrófica (CMH) através da variabilidade da freqüência cardíaca (VFC) e correlacioná-la com dados ecocardiográficos. MÉTODOS: Foram ...estudados 2 grupos pareados por sexo, idade e freqüência cardíaca: A) 10 pacientes com CMH septal (70% não obstrutiva); B) 10 voluntários saudáveis. A VFC foi analisada durante quatro estágios sucessivos: repouso, respiração controlada, teste de inclinação e respiração controlada associada ao teste de inclinação. Compararam-se as médias das variáveis entre os grupos, intragrupos durante os estágios, e no grupo A, correlacionando com as medidas ecocardiográficas (septo interventricular e diâmetro atrial esquerdo). RESULTADOS: Não observamos diferença na VFC entre os grupos nos 3 primeiros estágios. No 4º estágio, constatamos que medidas de atividade vagal apresentaram valores maiores no grupo A logaritmo da raiz média quadrática das diferenças entre intervalos RR (LogRMSSD) - 1,35±0,14 vs 1,17±0,16; p=0,019; logaritmo do componente alta freqüência (LogAF)-4,89±0,22 vs 4,62±0,26; p=0,032. Durante os estágios, também verificamos que medidas vagais proporção de pares de intervalos RR consecutivos cuja diferença > 50ms (pNN50) e LogAF apresentaram menor redução durante o 3º estágio no grupo A, e o LogAF, um aumento no último estágio (p=0,027), indicando marcante atividade parassimpática neste grupo. A análise da VFC do grupo A não revelou diferença entre pacientes com maior hipertrofia ou diâmetro atrial. CONCLUSÃO: 1) ocorreu predomínio parassimpático durante estimulação autonômica nos pacientes com CMH; 2) não encontramos correlação entre VFC e as medidas ecocardiográficas analisadas.
The International Space Exploration Coordination Group (ISECG) formed two Gap Assessment teams to evaluate topic discipline areas that had not been worked at an international level to date. ...Accordingly, the ISECG Technology Working Group (TWG) recommended two discipline areas based on Global Exploration Roadmap (GER) Critical Technology Needs reflected within the GER Technology Development Map (GTDM): Dust Mitigation and LOX/Methane Propulsion, with this paper addressing the former. The ISECG approved the recommended Gap Assessment teams, and tasked the TWG to formulate the new teams with subject matter experts (SMEs) from the participating agencies. The participating agencies for the Dust Mitigation Gap Assessment Team were ASI, CSA, ESA, JAXA, and NASA. The team was asked to identify and make a presentation on technology gaps related to the GER2 mission scenario (including cislunar and lunar mission themes and long-lead items for human exploration of Mars) at the international level. In addition the team was tasked to produce a gap assessment in the form of a summary report and presentation identifying those GER Critical Technology Needs, including opportunities for international coordination and cooperation in closing the identified gaps. Dust is still a principal limiting factor in returning to the lunar surface for missions of any extended duration. However, viable technology solutions have been identified, but need maturation to be available to support both lunar and Mars missions.
The International Space Exploration Coordination Group (ISECG) formed two Gap Assessment teams to evaluate topic discipline areas that had not been worked at an international level to date. ...Accordingly, the ISECG Technology Working Group (TWG) recommended two discipline areas based on Global Exploration Roadmap (GER) Critical Technology Needs reflected within the GER Technology Development Map (GTDM): Dust Mitigation and LOX/Methane Propulsion, with this paper addressing the former. The ISECG approved the recommended Gap Assessment teams, and tasked the TWG to formulate the new teams with subject matter experts (SMEs) from the participating agencies. The participating agencies for the Dust Mitigation Gap Assessment Team were ASI, CSA, ESA, JAXA, and NASA. The team was asked to identify and make a presentation on technology gaps related to the GER2 mission scenario (including cislunar and lunar mission themes and long-lead items for human exploration of Mars) at the international level. In addition the team was tasked to produce a gap assessment in the form of a summary report and presentation identifying those GER Critical Technology Needs, including opportunities for international coordination and cooperation in closing the identified gaps. Dust is still a principal limiting factor in returning to the lunar surface for missions of any extended duration. However, viable technology solutions have been identified, but need maturation to be available to support both lunar and Mars missions.
PDF
